Partial Thromboplastin Time (PTT) Test: Normal Range, Interpretation & Clinical Use
Reference Range
- Typical: 25–35 seconds (varies by lab/reagent/instrument).
- Always use the performing lab's reference interval.
What PTT Measures
Time for clot formation via the **intrinsic + common pathway** after adding phospholipid (partial thromboplastin) and contact activator (kaolin, silica, ellagic acid) to citrated plasma.
Factors Assessed
- Factors XII, XI, IX, VIII, X, V, II (prothrombin), Fibrinogen.
- Prekallikrein, high-molecular-weight kininogen (contact factors).
- Inhibitors: Heparin, lupus anticoagulant, specific factor inhibitors.
Clinical Indications
- Monitor **unfractionated heparin** (target 1.5–2.5 × control).
- Screen for **hemophilia A/B** (VIII, IX deficiency).
- Evaluate **von Willebrand disease** (vWF carries VIII).
- Pre-op bleeding risk assessment.
- DIC, liver disease, lupus anticoagulant workup.
Interpretation of Abnormal Results
| Pattern | Suggests |
|---|---|
| Prolonged PTT, normal PT | Intrinsic pathway factor deficiency (VIII, IX, XI, XII), heparin, lupus anticoagulant |
| Prolonged PTT + PT | Common pathway (X, V, II, fibrinogen), liver disease, DIC, warfarin |
| Shortened PTT | Acute phase (elevated VIII/fibrinogen), early DIC, technical error |
